Brief: Lyka Labs Considered Issue Of Shares Upon Conversion Of Warrants To IPCA Laboratories
18/04/2023 08:33
April 18 (Reuters) - IPCA Laboratories Ltd IPCA.NS :
* LYKA LABS LTD - CONSIDERED ISSUE OF 2.4 MILLION SHARES
UPON
CONVERSION OF WARRANTS TO IPCA LABORATORIES
Source text for Eikon: ID:nBSE2W4l8J
Further company coverage: IPCA.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Lyka Labs
See all newsBrief: Lyka Labs Gets Tribunal Order To Receive 6.3 Million Rupees From Modi Life Care
Brief: Lyka Labs Gets Indian Patent For Pregabalin Gel 8% Valid Through 2043
India's Lyka Labs secures drug patent for diabetes-related conditions; shares surge
India's Lyka Labs climbs after regulatory body approves Pregabalin Gel
Brief: Lyka Labs Gets Permission From CDSCO To Manufacture, Market Pregabalin Gel 8% W/W In India